Randomized trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/Gynecologic oncology group study

  • Joan L. Walker
  • , Mark F. Brady
  • , Lari Wenzel
  • , Gini F. Fleming
  • , Helen Q. Huang
  • , Paul A. DiSilvestro
  • , Keiichi Fujiwara
  • , David S. Alberts
  • , Wenxin Zheng
  • , Krishnansu S. Tewari
  • , David E. Cohn
  • , Matthew A. Powell
  • , Linda Van Le
  • , Susan A. Davidson
  • , Heidi J. Gray
  • , Peter G. Rose
  • , Carol Aghajanian
  • , Tashanna Myers
  • , Angeles Alvarez Secord
  • , Stephen C. Rubin
    • Robert S. Mannel

Research output: Contribution to journal › Article › peer-review

210 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/Gynecologic oncology group study'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions